HomeCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Previous close
$7.33
Year range
$5.25 - $22.20
Market cap
2.03M USD
Avg Volume
370.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.00K | -98.93% |
Operating expense | 3.65M | -42.11% |
Net income | -3.26M | 40.22% |
Net profit margin | -81.42K | -5,474.80% |
Earnings per share | -0.72 | 89.09% |
EBITDA | -3.64M | 38.49% |
Effective tax rate | 11.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.00M | -40.97% |
Total assets | 8.19M | -50.19% |
Total liabilities | 7.19M | -36.40% |
Total equity | 999.00K | — |
Shares outstanding | 1.97M | — |
Price to book | 13.33 | — |
Return on assets | -126.92% | — |
Return on capital | 1,542.76% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -3.26M | 40.22% |
Cash from operations | -3.08M | -136.32% |
Cash from investing | — | — |
Cash from financing | 6.29M | 12,431.37% |
Net change in cash | 3.20M | 351.93% |
Free cash flow | -2.94M | -93.08% |
About
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
Founded
Aug 13, 1996
Headquarters
Website
Employees
12
